A ray of hope amid the pandemic emerged Wednesday in early U.S. trials for potential COVID-19 treatment remdesivir. The antiviral medication shows "a clear-cut, significant, positive effect" in shortening recovery times, said Dr. Anthony Fauci, who advises President Donald Trump and runs the agency conducting the research. Patients on remdesivir saw hospitalization times cut from 15 to 11 days. The news boosted global markets, along with the U.S. Federal Reserve's decision to "use its full range of tools" to buoy a crumbling economy. Meanwhile, U.S. virus deaths passed 60,000 — likely undercounted as "other" deaths have spiked.
Follow OZY's comprehensive pandemic coverage.